goldfinger
- 01 Sep 2004 15:33
This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.
Heres the latest news from Killik stocbrokers on the company..........
MEDICAL MARKETING Joint Venture
We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.
Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.
This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)
The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.
Please DYOR
cheers GF.
mickeyskint
- 12 Apr 2005 09:33
- 1231 of 2444
I think there's a copy right issue Chiva.
MS
Chiva20
- 12 Apr 2005 09:36
- 1232 of 2444
Thanks MS no worries - what is causing this to bottom out again? The sentiment should be positive, but there are some jitters ..
mitzy
- 12 Apr 2005 09:51
- 1233 of 2444
I expect jitters for a while yet until the shorting period closes and a trading range of 170-200p.But the next bit of news will push them higher past 200p.
Chiva20
- 12 Apr 2005 10:04
- 1234 of 2444
Thanks Mitzy, holding for long term but good to know where we're headed in the meantime.
mickeyskint
- 12 Apr 2005 10:48
- 1235 of 2444
Just be patient and keep the faith. Don't be scared off.
LOL
MS
doughboy66
- 12 Apr 2005 10:57
- 1236 of 2444
I agree Mickey. good news is comming (don`t miss the boat and don`t let Evil have your shares on the cheap!!!! )
DB66
goldfinger
- 12 Apr 2005 12:44
- 1237 of 2444
Im not a member Chiva of the M Walters site. Im just repeating what I have seen on other boards. Looks to me like traders are taking the profit they made yesterday. Like DB says its just a case of holding your nerve until the new news hopefully at the month end.
cheers GF.
goldfinger
- 12 Apr 2005 16:14
- 1238 of 2444
Buyers coming back in at the end of the day picking shares up on the cheap.
cheers GF.
mickeyskint
- 12 Apr 2005 16:31
- 1239 of 2444
From the other place.
simon cawkwell is being investigated by the sfo together with tips.com
MD
goldfinger
- 12 Apr 2005 16:37
- 1240 of 2444
Whats the sfo?.
cheers GF.
bhunt1910
- 12 Apr 2005 16:41
- 1241 of 2444
Serious Fraud Office ?
goldfinger
- 12 Apr 2005 16:44
- 1242 of 2444
Blimey. Cant see what they have done wrong though. Surely its Peel Hunt and their ex- analyst who should be investigated?.
cheers GF.
mickeyskint
- 12 Apr 2005 16:53
- 1243 of 2444
I agree GF. EK was doing what he always does, even though I think it despicable.
MS
goldfinger
- 12 Apr 2005 23:07
- 1244 of 2444
We just have to accept shorting and get on with it Mickey. They have been there from year dot. I must admit I dont really like it and nobody as ever yet convinced me we need it.
cheers GF.
hlyeo98
- 13 Apr 2005 07:17
- 1245 of 2444
GREAT news...this will burn EK's ass!
Medical Marketing Int'l Group PLC
13 April 2005
For Immediate Release 13 April 2005
MEDICAL MARKETING INTERNATIONAL GROUP PLC
FURTHER PATENT GRANT FOR MMI'S GENVAX
Medical Marketing International Group plc (LSE: MMG), the Cambridge, UK-based
pharmaceutical development company announces that it has received a notification
of intention to grant in Europe for a patent covering immunostimulants for DNA
vaccines. The new patent further strengthens Genvax's portfolio of
immunostimulant DNA vaccines.
Notification of intention to grant of new European patent for DNA vaccine
EU patent for tetanus toxin DNA vaccines already granted
Preliminary results for first clinical trial already announced
Three further trials ongoing and others planned for 2005
Genvax, a joint-venture between MMI Group and scientists at Southampton
University was formed in January 2004 to commercially develop DNA vaccines for
cancer and infectious diseases. On 22 March 2005 Genvax announced that it had
reached agreement with Cancer Research Technology, the commercial arm of Cancer
Research UK, under which Genvax acquired the exclusive worldwide rights to
intellectual property surrounding the DNA vaccines, including a European patent
for the use of tetanus toxin constructs for vaccines. This patent was entered
into the Register of European Patents in November 2004. Today's announcement
concerns a further patent that protects the use of other immunogenic stimulants
to treat cancer.
On 22 March 2005 Genvax also announced that Professor Freda Stevenson, Research
Director of Genvax, had presented preliminary results for a clinical trial
involving the use of the DNA vaccines in 25 patients suffering from follicular
lymphoma. The announcement also noted that MMI had agreed to invest further
funds into Genvax to progress the commercialisation of the cancer vaccines. This
investment would also increase MMI's stake in Genvax from 50% to 58%.
Commenting on today's news, Mark Burton, Technology Manager at MMI and Technical
Director of Genvax said: 'Given the clinical results from the lymphoma trial
which has been principally supported by The Leukaemia Research Fund and Cancer
Research UK we are delighted that we are able to show investors that we have
further strengthened our patent position in this exciting field. Working closely
with the cancer charities we look forward to the results of the ongoing myeloma
trials and the prostate cancer trial and to seeing other DNA vaccine trials
start this year. With the National Blood Service we are also looking forward to
developing advanced manufacturing systems and together we all look forward to
improving the treatment of cancer patients as well as creating enhanced value
for shareholders.'
Chiva20
- 13 Apr 2005 09:18
- 1246 of 2444
It's struggling with this 200p resistance, would be nice to see it march through today.
mickeyskint
- 13 Apr 2005 10:16
- 1247 of 2444
I think it will bounce between support and resistance points untill May when we are due more news.
MS
goldfinger
- 13 Apr 2005 10:40
- 1248 of 2444
Good news. Yes I think we will see a lot of volatility with this one until the biggy news late this month or early next.
cheers GF.
mickeyskint
- 13 Apr 2005 15:30
- 1249 of 2444
Looks like EK might have over stepped the mark. From the other place. Please note I've grabbed the header this time. Don't want to dent anyone's ego.
harry punter - 13 Apr'05 - 04:38 - 4820 of 4867
my dear simon --informed city sources and brokers are very concerned about a fresh sfo enquiry currently underway into your contentious share dealing and business activities ---unlike the fsa -the sfo do have the powers to investigate and arrest non regulated punters in the public -who carry out unregulated business -- have been now fully alerted by peel hunt about an illegal share dealing ring currently in operation and are investigating yourself and others --looks like spotted dick and custard and 23 hour a day bang up for you --and a quick jog around the exercise yard if your a good boy --
be careful in the showers though simon as half the inmates because of you may have done there bollocks on being long and not short---
regards harry and the boys in dark glasses
MS
goldfinger
- 13 Apr 2005 16:18
- 1250 of 2444
LOL, hes still in short though but must admit he was very withdrawn on his comments on the board today. Hmm.
cheers GF.